---
title: "Clearbridge Health Limited (1H3.SG)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/1H3.SG.md"
symbol: "1H3.SG"
name: "Clearbridge Health Limited"
industry: "Health Care Services"
datetime: "2026-05-21T13:49:48.708Z"
locales:
  - [en](https://longbridge.com/en/quote/1H3.SG.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/1H3.SG.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/1H3.SG.md)
---

# Clearbridge Health Limited (1H3.SG)

## Company Overview

Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, and internationally. It operates through Medical Clinics/Centres and Strategic Investments segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, magnetic resonance imaging, and ultrasound; general health services, such as diabetes, high blood pressure, and high cholesterol screening; and vaccination services. It also offers aesthetics, dental and orthodontics, dermatology, diagnostics radiology, infectious diseases, internal medicine, medical, oncology, obstetrics and gynaecology, and rental medicine services.

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Exchange | SG Market |
| Website | [www.clearbridgehealth.com](https://www.clearbridgehealth.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:16.000Z

**Overall: C (0.60)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 13 / 15 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.26% |  |
| Net Profit YoY | -257.76% |  |
| P/B Ratio | 1.25 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4282317.12 |  |
| Revenue | 9897788.66 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -203.89% | E |
| Profit Margin | -130.00% | E |
| Gross Margin | 50.97% | B |
| Revenue YoY | 0.26% | C |
| Net Profit YoY | -257.76% | E |
| Total Assets YoY | -53.63% | E |
| Net Assets YoY | -52.60% | E |
| Cash Flow Margin | 21.30% | D |
| OCF YoY | 0.26% | C |
| Turnover | 0.64 | B |
| Gearing Ratio | 46.76% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Clearbridge Health Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.26%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-257.76%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.25",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "4282317.12",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "9897788.66",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-203.89%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-130.00%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "50.97%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "0.26%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-257.76%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-53.63%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-52.60%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "21.30%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "0.26%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.64",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "46.76%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.67 | 8/15 | - | - | - |
| PB | 2.49 | 9/15 | 1.25 | 1.06 | 0.70 |
| PS (TTM) | 0.87 | 6/15 | 1.25 | 0.84 | 0.67 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | HC Surgical (1B1.SG) | A | C | B | A | C | B |
| 02 | Alliance HC (MIJ.SG) | B | B | A | D | B | B |
| 03 | Medinex (OTX.SG) | B | C | B | A | C | B |
| 04 | AsiaMedic (505.SG) | B | B | B | D | B | B |
| 05 | Livingstone Health (PRH.SG) | B | B | A | D | A | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/1H3.SG/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/1H3.SG/norm.md)
- [Related News](https://longbridge.com/en/quote/1H3.SG/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**